Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Apotex Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1354)
Cancellation or suspension (47)
Prescription medicine registration (18)
ARTG (8)
Australian Public Assessment Report (AusPAR) (1)
Listed medicine compliance report (1)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2024 (4)
2023 (16)
2022 (159)
2021 (104)
2020 (216)
2019 (124)
2018 (380)
2017 (307)
2016 (37)
2015 (52)
2014 (32)

Results for "[search-keyword]"

Search

Sponsor content

1431 result(s) found, displaying 201 to 210

APO-TRANDOLAPRIL trandolapril 4 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-CALCITRIOL calcitriol 0.25 microgram capsule bottle Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-TRANDOLAPRIL trandolapril 1 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-TRANDOLAPRIL trandolapril 2 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-Telmisartan HCTZ 80/12.5mg tablet bottle Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-DORZOLAMIDE dorzolamide (as hydrochloride) 20 mg/mL eye drops bottle Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-Valsartan HCTZ 80/12.5 valsartan 80 mg and hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-Valsartan HCTZ 160/25 valsartan 160 mg and hydrochlorothiazide 25 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
GENRX GABAPENTIN gabapentin 600mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd
CHEMMART SILDENAFIL sildenafil (as citrate) 100mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Apotex Pty Ltd

Pages

First page
Previous page
…
Page 17
Page 18
Page 19
Page 20
Current page 21
Page 22
Page 23
Page 24
Page 25
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.